Demeclocycline: Difference between revisions
Gerald Chi (talk | contribs) No edit summary |
No edit summary |
||
| (5 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{ | __NOTOC__ | ||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Demeclocycline''' (marketed as Declomycin, Declostatin, and Ledermycin) is a [[tetracycline antibiotic]] derived from a strain of ''[[Streptomyces aureofaciens]]''. | |||
===== | ==Uses== | ||
It is officially indicated for the treatment of various types of [[bacteria]]l [[infection]]s.<ref name="urlDailyMed: About DailyMed">{{cite web |url=http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=673 |title=DailyMed: About DailyMed |format= |work= |accessdate=2008-12-20}}</ref> It is used as an antibiotic in the treatment of [[Lyme disease]], [[Acne vulgaris|acne]], and [[bronchitis]]. Resistance, though, is gradually becoming more common, and demeclocycline is now rarely used for infections. | |||
It is widely used (though [[off-label use|off-label]] in many countries) in the treatment of [[hyponatremia]] (low blood [[sodium]] concentration) due to the [[syndrome of inappropriate antidiuretic hormone]] (SIADH) when fluid restriction alone has been ineffective.<ref name=Goh>{{cite journal |author=Goh KP |title=Management of hyponatremia |journal=[[American Family Physician]] |volume=69 |issue=10 |pages=2387–94 |date=May 2004 |pmid=15168958 |url=http://www.aafp.org/afp/20040515/2387.html}}</ref> Physiologically, this works by reducing the responsiveness of the collecting tubule cells to ADH. | |||
The use in SIADH actually relies on a side effect; demeclocycline induces [[diabetes insipidus|nephrogenic diabetes insipidus]] (dehydration due to the inability to concentrate urine).<ref name=Goh/> The use of demeclocycline in SIADH was first reported in 1975,<ref name="Cherrill">{{cite journal |author=Cherrill DA, Stote RM, Birge JR, Singer I |title=Demeclocycline treatment in the syndrome of inappropriate antidiuretic hormone secretion |journal=[[Annals of Internal Medicine]] |volume=83 |issue=5 |pages=654–6 |date=November 1975 |pmid=173218 |doi=10.7326/0003-4819-83-5-654}}</ref> and, in 1978, a larger study found it to be more effective and better tolerated than [[lithium carbonate]], the only available treatment at the time.<ref name=Tolstoi>{{cite journal |author=Tolstoi LG |title=A brief review of drug-induced syndrome of inappropriate secretion of antidiuretic hormone |journal=[[Medscape|Medscape Pharmacotherapy]] |volume=4 |issue=1 |year=2002 |url=http://www.medscape.com/viewarticle/420687_print}} Retrieved on October 27, 2008.</ref> Demeclocycline has since been the drug of choice for treating SIADH, although it may be superseded as [[vasopressin receptor antagonist]]s, such as [[tolvaptan]], become available.<ref name=Tolstoi/> | |||
| | |||
==Contraindications== | |||
Like [[tetracycline antibiotics|other tetracyclines]], demeclocycline is contraindicated in children and pregnant or nursing women. All members of this class interfere with [[bone]] development and may discolour [[tooth|teeth]]. | |||
==Side effects and interactions== | |||
These are similar to those of other tetracyclines. Skin reactions with sunlight have been reported. Demeclocycline is unique in that it is the only tetracycline known to cause nephrogenic diabetes insipidus. | |||
Tetracyclines bind to [[cation]]s, such as [[calcium]], [[iron]] (when given orally), and [[magnesium]], rendering them insoluble and inabsorbable for the gastrointestinal tract. Demeclocycline should not be taken with food (particularly milk and other dairy products) or [[antacid]]s. | |||
==Mechanism of action== | |||
As with related tetracycline antibiotics, demeclocycline acts by binding to the [[30S]] ribosomal subunit to inhibit binding of aminoacyl tRNA which impairs [[protein synthesis]] by bacteria. It is [[bacteriostatic]] (it impairs bacterial growth, but does not kill bacteria directly). | |||
It is not completely understood why demeclocycline impairs the action of [[antidiuretic hormone]], but is thought to block the binding of the hormone from its [[receptor (biochemistry)|receptor]].<ref>{{cite journal |doi=10.1056/NEJM197510302931809 |author=De Troyer A, Demanet JC |title=Correction of antidiuresis by demeclocycline |journal=N Engl J Med |volume=293 |issue=18 |pages=915–8 |year=1975 |pmid=170519}}</ref> | |||
==== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Tetracycline antibiotics]] | |||
[[Category:Organochlorides]] | |||
[[Category:Amides]] | |||
: | |||
Latest revision as of 23:30, 30 June 2014
|
WikiDoc Resources for Demeclocycline |
|
Articles |
|---|
|
Most recent articles on Demeclocycline Most cited articles on Demeclocycline |
|
Media |
|
Powerpoint slides on Demeclocycline |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Demeclocycline at Clinical Trials.gov Trial results on Demeclocycline Clinical Trials on Demeclocycline at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Demeclocycline NICE Guidance on Demeclocycline
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Demeclocycline Discussion groups on Demeclocycline Patient Handouts on Demeclocycline Directions to Hospitals Treating Demeclocycline Risk calculators and risk factors for Demeclocycline
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Demeclocycline |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Demeclocycline (marketed as Declomycin, Declostatin, and Ledermycin) is a tetracycline antibiotic derived from a strain of Streptomyces aureofaciens.
Uses
It is officially indicated for the treatment of various types of bacterial infections.[1] It is used as an antibiotic in the treatment of Lyme disease, acne, and bronchitis. Resistance, though, is gradually becoming more common, and demeclocycline is now rarely used for infections.
It is widely used (though off-label in many countries) in the treatment of hyponatremia (low blood sodium concentration) due to the syndrome of inappropriate antidiuretic hormone (SIADH) when fluid restriction alone has been ineffective.[2] Physiologically, this works by reducing the responsiveness of the collecting tubule cells to ADH.
The use in SIADH actually relies on a side effect; demeclocycline induces nephrogenic diabetes insipidus (dehydration due to the inability to concentrate urine).[2] The use of demeclocycline in SIADH was first reported in 1975,[3] and, in 1978, a larger study found it to be more effective and better tolerated than lithium carbonate, the only available treatment at the time.[4] Demeclocycline has since been the drug of choice for treating SIADH, although it may be superseded as vasopressin receptor antagonists, such as tolvaptan, become available.[4]
Contraindications
Like other tetracyclines, demeclocycline is contraindicated in children and pregnant or nursing women. All members of this class interfere with bone development and may discolour teeth.
Side effects and interactions
These are similar to those of other tetracyclines. Skin reactions with sunlight have been reported. Demeclocycline is unique in that it is the only tetracycline known to cause nephrogenic diabetes insipidus.
Tetracyclines bind to cations, such as calcium, iron (when given orally), and magnesium, rendering them insoluble and inabsorbable for the gastrointestinal tract. Demeclocycline should not be taken with food (particularly milk and other dairy products) or antacids.
Mechanism of action
As with related tetracycline antibiotics, demeclocycline acts by binding to the 30S ribosomal subunit to inhibit binding of aminoacyl tRNA which impairs protein synthesis by bacteria. It is bacteriostatic (it impairs bacterial growth, but does not kill bacteria directly).
It is not completely understood why demeclocycline impairs the action of antidiuretic hormone, but is thought to block the binding of the hormone from its receptor.[5]
References
- ↑ "DailyMed: About DailyMed". Retrieved 2008-12-20.
- ↑ 2.0 2.1 Goh KP (May 2004). "Management of hyponatremia". American Family Physician. 69 (10): 2387–94. PMID 15168958.
- ↑ Cherrill DA, Stote RM, Birge JR, Singer I (November 1975). "Demeclocycline treatment in the syndrome of inappropriate antidiuretic hormone secretion". Annals of Internal Medicine. 83 (5): 654–6. doi:10.7326/0003-4819-83-5-654. PMID 173218.
- ↑ 4.0 4.1 Tolstoi LG (2002). "A brief review of drug-induced syndrome of inappropriate secretion of antidiuretic hormone". Medscape Pharmacotherapy. 4 (1). Retrieved on October 27, 2008.
- ↑ De Troyer A, Demanet JC (1975). "Correction of antidiuresis by demeclocycline". N Engl J Med. 293 (18): 915–8. doi:10.1056/NEJM197510302931809. PMID 170519.